Sooty Tern (Onychoprion fuscatus)

Within-colony determinants of Sooty Tern post-fledging survival revisited: effect of body mass and relative time of fledging

“…This suggested that nesting early provided benefits additional to those conferred by nesting synchronously. Little is known of the post-fledging life of juveniles (Schreiber et al 2002, Jacquemet 2010 but once young fledge they will be freed from geographical restriction to food supplies around the breeding colony and able to move to more remote locations of food abundance, as long as they can locate such food sources. In this, social behaviour, in the form of local enhancement and/or information exchange (Shaeler 2002), will facilitate feeding opportunities.…”

“…Young Sooty Terns undergo a long period of deferred maturity (Schreiber et al 2002) during which they have not been recorded in the Bird Island colony. On Bird Island we have found one three-year-old bird incubating, but most do not return to breed until five years old; all appear to do so by six years old (Feare & Doherty 2011).…”

Loss of Darvic rings from Sooty Terns Onychoprion fuscatus in Seychelles

“…After fledging, most juvenile Sooty Terns are not recorded in breeding colonies until they return to breed, generally when four to eight years old (Harrington 1974, Schreiber et al 2002. During their absence from breeding colonies they are believed to remain at sea, flying continuously as their poor feather waterproofing does not allow them to settle on water (Ashmole 1963, Johnston 1979, Schreiber et al 2002.…”

“…The reasons for their failure on Sooty Terns are unclear. With the species' largely aerial lifestyle (Schreiber et al 2002), abrasion is unlikely to be a contributory factor but high ambient temperature and ultraviolet radiation in the tropical oceanic environment might be involved in the deterioration of the plastic.…”

Recombinant antibodies in infectious disease

“…Treating P. aeruginosa infections with antibiotic regimens has become increasingly difficult since the antibiotic-resistant strains have arisen. The emergence of passive antibody therapy for the prevention and treatment of Pseudomonas infections could be facilitated by the generation of recombinant human mAbs against bacterial lipopolysaccharide (LPS) using transgenic mice [126].…”